Sarepta Therapeutics
SRPT
SRPT
317 hedge funds and large institutions have $7.9B invested in Sarepta Therapeutics in 2018 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 74 increasing their positions, 124 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
317
Holders Change
+48
Holders Change %
+17.84%
% of All Funds
7.27%
Holding in Top 10
13
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+116.67%
% of All Funds
0.3%
New
87
Increased
74
Reduced
124
Closed
38
Calls
$349M
Puts
$322M
Net Calls
+$27.4M
Net Calls Change
-$59.3M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$182M |
| 2 |
State Street
Boston,
Massachusetts
|
-$101M |
| 3 |
JPMorgan Chase & Co
New York
|
-$67.2M |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$56.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$54.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
APA
351
American Portfolios Advisors
Holbrook,
New York
| – | -$25.9K | -350 | Closed |
|
352
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$20K | -275 | Closed |
|
353
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$11K | -152 | Closed |
|
|
APP
354
Avantax Planning Partners
Dubuque,
Iowa
| – | -$7K | -99 | Closed |
|
|
ML
355
McAdam LLC
Philadelphia,
Pennsylvania
| – | -$6K | -80 | Closed |
|